Clinical Trials Directory

Trials / Completed

CompletedNCT01149642

Randomised Study of Mucositis Prevention After Radiochemotherapy Treatment for Head and Neck Cancer

Phase III Multicenter, Randomised and Double-blind Study Comparing an Oral Immunomodulatory Solution Versus a Placebo in Preventing Severe Acute Mucositis in Head and Neck Cancer Patients Treated Surgically and Concomitantly With Radiochemotherapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This randomised, double-blind study will compare an oral immunomodulatory solution to a placebo for the prevention of acute severe mucositis in head and neck cancer patients treated surgically and concomitantly with radiochemotherapy. The investigators expect a decrease of 25% of severe acute mucositis in experimental arm.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOral ImpactThe patients will benefit in each case from a similar energy supplement (either Oral Impact or placebo) during the 5 days preceding the course of chemotherapy. They will receive the supplement 3 times per day at 10am, 3pm and 5pm outside of their meals. In total, the patients will take the supplements for 15 days (3 courses of 5 days). If the patient has difficulty taking the treatment orally, it can be given via an enteral tube (nasogastric tube or percutaneous gastrostomy). All patients in the protocol will systematically receive a dietetic consultation. This consultation by a dietician will detect malnutrition and result in nutritional counsel if necessary (advice re. enrichment of diet, CNO without immunonutrients, artificial nutrition). Follow-up appointments with a dietician will be organised every 3 weeks to maintain adherence to the suggested dietary changes.
DIETARY_SUPPLEMENTPlaceboThe placebo is an identical formula to the Oral Impact but is not enriched with specific nutrients.

Timeline

Start date
2009-11-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2010-06-23
Last updated
2020-08-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01149642. Inclusion in this directory is not an endorsement.